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Cysteine scanning mutagenesis
Abstract
The putative first intracellular and third extracellular linkers are known to play important roles in
defining the transport properties of the type IIa Na+-coupled phosphate cotransporter (Kohler, K., I.C.
Forster, G. Stange, J. Biber, and H. Murer. 2002b. J. Gen. Physiol. 120:693-705). To investigate
whether other stretches that link predicted transmembrane domains are also involved, the substituted
cysteine accessibility method (SCAM) was applied to sites in the predicted first and fourth extracellular
linkers (ECL-1 and ECL-4). Mutants based on the wild-type (WT) backbone, with substituted novel
cysteines, were expressed in Xenopus oocytes, and their function was assayed by isotope uptake and
electrophysiology. Functionally important sites were identified in both linkers by exposing cells to
membrane permeant and impermeant methanethiosulfonate (MTS) reagents. The cysteine modification
reaction rates for sites in ECL-1 were faster than those in ECL-4, which suggested that the latter were
less accessible from the extracellular medium. Generally, a finite cotransport activity remained at the
end of the modification reaction. The change in activity was due to altered voltage-dependent kinetics of
the Pi-dependent current. For example, cys substitution at Gly-134 in ECL-1 resulted in rate-limiting,
voltage-independent cotransport activity for V &lt; or = -80 mV, whereas the WT exhibited a linear
voltage dependency. After cys modification, this mutant displayed a supralinear voltage dependency in
the same voltage range. The opposite behavior was documented for cys substitution at Met-533 in
ECL-4. Modification of cysteines at two other sites in ECL-1 (Ile-136 and Phe-137) also resulted in
supralinear voltage dependencies for hyperpolarizing potentials. Taken together, these findings suggest
that ECL-1 and ECL-4 may not directly form part of the transport pathway, but specific sites in these
linkers can interact directly or indirectly with parts of NaPi-IIa that undergo voltage-dependent
conformational changes and thereby influence the voltage dependency of cotransport.
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abstract
 
The putative first intracellular and third extracellular linkers are known to play important roles in
defining the transport properties of the type IIa Na
 

 
-coupled phosphate cotransporter (Kohler, K., I.C. Forster, G.
Stange, J. Biber, and H. Murer. 2002b. 
 
J
 
. 
 
Gen
 
. 
 
Physiol
 
. 120:693–705). To investigate whether other stretches that link
predicted transmembrane domains are also involved, the substituted cysteine accessibility method (SCAM) was
applied to sites in the predicted first and fourth extracellular linkers (ECL-1 and ECL-4). Mutants based on the
wild-type (WT) backbone, with substituted novel cysteines, were expressed in 
 
Xenopus
 
 oocytes, and their function
was assayed by isotope uptake and electrophysiology. Functionally important sites were identified in both linkers
by exposing cells to membrane permeant and impermeant methanethiosulfonate (MTS) reagents. The cysteine
modification reaction rates for sites in ECL-1 were faster than those in ECL-4, which suggested that the latter were
less accessible from the extracellular medium. Generally, a finite cotransport activity remained at the end of the
modification reaction. The change in activity was due to altered voltage-dependent kinetics of the P
 
i
 
-dependent
current. For example, cys substitution at Gly-134 in ECL-1 resulted in rate-limiting, voltage-independent cotransport
activity for 
 
V
 
 
 

 
 
 

 
80 mV, whereas the WT exhibited a linear voltage dependency. After cys modification, this
mutant displayed a supralinear voltage dependency in the same voltage range. The opposite behavior was
documented for cys substitution at Met-533 in ECL-4. Modification of cysteines at two other sites in ECL-1 (Ile-136
and Phe-137) also resulted in supralinear voltage dependencies for hyperpolarizing potentials. Taken together,
these findings suggest that ECL-1 and ECL-4 may not directly form part of the transport pathway, but specific
sites in these linkers can interact directly or indirectly with parts of NaPi-IIa that undergo voltage-dependent
conformational changes and thereby influence the voltage dependency of cotransport.
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I N T R O D U C T I O N
 
The task of reabsorbing inorganic phosphate (P
 
i
 
) at
the brush border membrane of the renal proximal
tubule is largely fulfilled by the type IIa Na
 

 
/P
 
i
 
 cotrans-
porter (NaPi-IIa) (SLC34A1) and consequently this
protein plays a central role in mammalian phosphate
homeostasis (for review see Murer et al., 2000, 2003).
NaPi-IIa isoforms from several species have been
cloned and their transport kinetics characterized by
expression in 
 
Xenopus laevis
 
 oocytes using isotope tracer
and electrophysiological assays (for review see Forster
et al., 2002). The key functional features are as follows:
Na
 

 
-dependent P
 
i
 
 cotransport (3:1 Na
 

 
:P
 
i
 
 stoichiometry),
ordered substrate binding (Na
 

 
–P
 
i
2
 

 
–2Na
 

 
), substrate
specificity (divalent P
 
i
 
 is the preferred species), and
voltage-dependent transport (one net charge transfer per
transport cycle); uniport or uncoupled Na
 

 
-dependent
leak in the absence of P
 
i
 
; and intrinsic pH dependency
(suppressed P
 
i
 
 transport with external acidification)
(Forster et al., 2002). Elucidation of the structure–
function relationships between molecular entities and
kinetic properties of NaPi-IIa is an ongoing challenge
that we are currently addressing using the substituted
cysteine accessibility method (SCAM) (e.g., Karlin and
Akabas, 1998).
The predicted topology of NaPi-IIa, derived from
studies on the rat isoform, suggests a protein with
eight transmembrane domains, a large extracellular loop
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Cysteine Scanning of Extracellular Linkers in NaPi-IIa
 
with two N-glycosylation sites and intracellular NH
 
2
 
 and
COOH termini (Magagnin et al., 1993; Murer et al.,
2000) (Fig. 1 A). Antibody accessibility studies (Lam-
bert et al., 1999b) and cysteine scanning approaches
(Lambert et al., 1999a, 2000; Kohler et al., 2002a,b)
also support this model. Using SCAM we have identi-
fied sites in the putative third extracellular linker (ECL-3)
(Lambert et al., 1999a, 2001) and the putative first
intracellular linker (ICL-1) (Kohler et al., 2002a,b)
that when modified by methanethiosulfonate (MTS)
reagents result in block of cotransport mode activity.
Given that NaPi-IIa is a functional monomer (Kohler et
al., 2000), and taking into account our previous SCAM
findings, we currently postulate that these two topologi-
cally opposed linker regions associate with one another
to constitute the transport pathway (Kohler et al.,
2002a,b). To examine if other external linker regions
may also define NaPi-IIa transport properties, we per-
formed SCAM on sites in the first and fourth predicted
linker regions, designated ECL-1 and ECL-4, respec-
tively (Fig. 1 A). As shown in Fig. 1 B, these regions are
very well conserved among several isoforms of the
SLC34A family and therefore we might expect them to
play common functional roles.
Cysteine substitution at nine sites in ECL-1 and four
sites in ECL-4 was well tolerated, and these mutants dis-
played no significant deviations from wild-type (WT)
behavior, based on a two-point screening assay for sub-
strate and cosubstrate activation. In both linker re-
gions, altered kinetic phenotypes were documented for
membrane-impermeant MTS reagents, which estab-
lished that these sites were accessible from the extracel-
lular milieu, in agreement with the current NaPi-IIa
secondary topology. Estimated rates of modification
suggested that ECL-1 was more accessible than ECL-4.
Some mutations in each linker showed significantly
modified voltage dependency before and after expo-
sure to MTS reagents. Of particular significance were
the complementary changes that resulted from in situ
molecular manipulations of certain residues in ECL-1
and ECL-4. Our results suggest that these linkers are
most likely not directly part of the transport pathway,
but they contain specific sites that may interact di-
rectly or indirectly with voltage-sensitive elements of
the NaPi-IIa protein.
 
M A T E R I A L S  A N D  M E T H O D S
 
Mutagenesis
 
Mutations were introduced following the Stratagene Quick-
change Site-Directed Mutagenesis Kit manual. 10 ng of the plas-
mid (pSPORT; GIBCO BRL) containing the WT rat NaPi-IIa
cDNA was amplified with 2.5 U of Pfu Turbo DNA polymerase
(Stratagene), in the presence of primers (200 nM). PCR amplifi-
cation was performed with 20 cycles, with each cycle consisting of
one 95
 

 
C (30 s), one 55
 

 
C (1 min), and one 68
 

 
C (15 min) step.
Afterwards, 10 U of Dpn I was added directly to the amplification
reaction, and the sample was incubated for 1 h at 37
 

 
C to digest
the parental DNA. XL1-blue supercompetent cells were trans-
formed with 1 
 

 
l of the reaction mixture and plated onto LB-
ampicillin plates. The sequence was verified by sequencing (Mi-
crosynth) and the plasmid linearized by digestion with NotI. In
vitro synthesis of capped cRNA was done following the Ambion
MEGAscript T7 kit manual (Ambion). In brief, 1 
 

 
g linearized
DNA encoding the rat NaPi-IIa constructs was incubated in the
presence of 40 U of T7 RNA polymerase and Cap Analogue (New
England Biolabs, Inc.) at 37
 

 
C for 4 h. Oocytes were injected with
either 50 nl water or 50 nl of water containing 10 ng cRNA.
 
Reagents and Solutions
 
All standard reagents were obtained from either Sigma-Aldrich
or Fluka. Methanethiosulfonate (MTS) reagents were obtained
from Toronto Research Chemicals (Downsview). The solution
compositions (in mM) were as follows. (a) Oocyte incubation
(modified Barth’s solution): NaCl (88), KCl (1), CaCl
 
2
 
 (0.41),
MgSO
 
4
 
 (0.82), NaHCO
 
3
 
 (2.5), Ca(NO
 
3
 
)
 
2
 
, HEPES (7.5), adjusted
to pH 7.6 with TRIS and supplemented with antibiotics (10 mg/l
gentamycin, streptomycin). (b) Control superfusate (ND100):
NaCl (100); KCl (2); CaCl
 
2
 
 (1.8); MgCl
 
2
 
 (1); HEPES-TRIS (10) at
pH 7.4. Solutions with intermediate Na
 

 
 concentrations were
prepared by mixing ND0 and ND100 in the appropriate propor-
tions. (c) Substrate test solutions: inorganic phosphate (P
 
i
 
) was
added to the control superfusate from 1 M K
 
2
 
HPO
 
4
 
 and KH
 
2
 
PO
 
4
 
stocks that were mixed to give the required pH (7.4 or 6.2).
Phosphonoformic acid (PFA) was added to ND100 from frozen
100 mM stock (in H
 
2
 
O) to yield a final concentration of 1 mM.
(d) MTS reagents, 2-aminoethyl MTS hydrobromide (MTSEA),
2-(trimethylammonium)ethyl MTS bromide (MTSET), and so-
dium (2-sulfonatoethyl) MTS (MTSES) were prepared from dry
stock in DMSO to give 1 M stock solutions. These were stored at
 

 
20
 

 
C until required and added to ice-cold ND100 solution. The
final concentration of DMSO did not exceed 0.1%, and DMSO
alone at this concentration was confirmed not to alter the kinetic
characteristics of the expressed constructs.
 
Immunoblotting of Oocyte Homogenates: Western Blotting
 
Yolk-free homogenates were prepared 3 d after injection of cRNA.
Pools of eight oocytes were lysed together with 160 
 

 
l homogeni-
zation buffer (1% eluent [Calbiochem] in 100 mM NaCl, 20 mM
Tris/HCl, pH 7.6) by pipetting the oocytes up and down (Turk et
al., 1996). To pellet the yolk proteins, samples were centrifuged at
16,000 
 
g
 
 for 3 min at 22
 

 
C. 10 
 

 
l supernatant was mixed with 10 
 

 
l
2
 

 
 loading buffer (4% SDS, 2 mM EDTA, 20% glycerol, 0.19 M
Tris/HCl, pH 6.8, 2 mg/ml bromphenol blue, 200 mM dithio-
threitol [DTT]), denatured for 2 min at 95
 

 
C and separated on a
10% SDS-PAGE gel. Separated proteins were transferred onto a
nitrocellulose membrane (Schleicher & Schuell). The membrane
was then processed according to standard procedures (Sambrook
et al., 1989) using a rabbit polyclonal antibody raised against a
synthetic peptide from the NH
 
2
 
 termini of the rat NaPi-IIa
cotransporter (dilution 1:2,000). The specificity of the antibody
has been demonstrated previously (Custer et al., 1994). Immu-
noreactive proteins were detected with a swine anti-rabbit Ig
horseradish peroxidase–linked F(ab
 

 
)
 
2
 
 secondary antibody (dilu-
tion 1:5,000) (Amersham Biosciences) and visualized with a chemi-
luminescence system (Pierce Chemical Co.).
 
Streptavidin Precipitation of MTSEA-biotinylated Protein
 
Groups of eight oocytes per NaPi-IIa mutant were incubated for
10 min in 1 mM MTSEA-Biotin, prepared as above. Oocytes ex-
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pressing the S460C or the WT protein were taken as positive and
negative control, respectively. Biotin-streptavidin precipitation
was performed as previously described (Lambert et al., 1999a).
In brief, after homogenization in 160 
 

 
l of homogenization
buffer and centrifugation (see immunoblot of oocyte homoge-
nates), a sample for Western blotting was taken. The rest of the
supernatant (
 

 
120 
 

 
l) was incubated for 2 h with 60 
 

 
l Immu-
noPure immobilized streptavidin beads (Pierce Chemical Co.)
on a rotator. After five washing steps with homogenization buffer,
precipitated proteins were eluted with 2
 

 
 loading buffer (includ-
ing DTT) at 95
 

 
C for 5 min. Samples were loaded on a 10% SDS
gel and immunoblotted after protein separation.
 
Functional Assays and Data Analysis
 
Radiolabeled P
 
i
 
 Uptake.
 
This procedure has been described in de-
tail elsewhere (Werner et al., 1990). 
 
32
 
P
 
i
 
 uptake was measured 3 d
after injection in water-injected (control) and cRNA-injected oo-
cytes (
 
n
 
 
 

 
 10).
 
Electrophysiology. 
 
The standard two-electrode voltage clamp
technique was used as previously described (Forster et al., 1998).
The voltage clamp was a laboratory-built system with membrane
current measured using a virtual ground bath electrode and with
active series resistance compensation to reduce clamp errors.
Oocytes were mounted in a small recording chamber (100 
 

 
l vol-
ume) and continuously superfused (5 ml/min) with test solu-
tions precooled to 
 

 
20
 

 
C. Data were acquired online using Digi-
data 1200 hardware and compatible pClamp8 software (Axon
Instruments, Inc.). Recorded currents were prefiltered at a band-
width less than twice the sampling rate (typically 20 Hz for fixed
voltage recording and 200 Hz for 
 
I
 
–
 
V
 
 determination).
 
Steady-state Current-Voltage (I–V) Relations. 
 
These were deter-
mined by using a voltage staircase from 
 

 
120 mV to 
 

 
40 mV
with 100-ms-long steps, as previously described (Forster et al.,
1998), and subtracting the response in the absence of substrate
(P
 
i
 
 or PFA) from that in the presence of substrate. Only single
sweeps were used.
 
Incubation with MTS Reagents and Determination of Rate of Modifi-
cation. 
 
Freshly prepared MTSEA/ET/ES (see above) was deliv-
ered to the oocyte chamber using a stainless steel cannula (inner
diameter 0.3 mm) positioned near the cell and fed by gravity. Re-
agents were always applied in the presence of ND100 at a holding
potential 
 
V
 
h
 
 
 
	
 
 
 

 
50 mV. Incubation was followed by a 1-min wash-
out period before applying P
 
i
 
 (1 mM) as the test assay. A further
1-min washout period was allowed before reincubation at the next
concentration of MTS reagent to ensure complete removal of
substrate and return of response to a steady-state holding current.
 
Cys Modification Reaction Rate. 
 
The effective second order re-
action rates were determined by fitting a single decaying expo-
nential to the peak P
 
i
 
-dependent current after a cumulative ex-
posure time 
 
t
 
, (
 
t
 
) determined following each successive MTS
exposure:
 
(1)
 
where 
 
0
 
 is the P
 
i
 
 response at 
 
t
 
 
 
	
 
 0; 
 

 
 
is the response at 
 
t
 
 
 
	
 
 
 


 
; 
 
c
 
is the concentration of MTS reagent (assumed to be in excess),
and 
 
k
 
* is the effective second order rate constant (Zhang and
Karlin, 1997; Karlin and Akabas, 1998).
All curve fitting was performed using GraphPad Prism version
3.02/4.02 for Windows (GraphPad Software).
IPi
IPi
t IPi
0 IPi
∞
–( )exp ctk*( ) IPi
∞
+ ,=
IPi IPi
Figure 1. (A) Topological representation of the
rat type IIa Na/Pi cotransporter comprises a
backbone of eight putative membrane-spanning
domains (TMD-1 to -8) and corresponding linker
regions. A functionally essential cysteine bridge is
formed between Cys-306 and Cys-334 in the
large second extracellular linker (ECL-2) and an
additional bridge between Cys-225 and either Cys-
520 or Cys-597 has also been recently proposed
(Kohler et al., 2003). The cluster of function-
ally important (MTS-accessible) sites previously
identified by SCAM in the third extracellular
linker (ECL-3) (Lambert et al., 2001) and two sites
in the first intracellular linker (ICL-1) (Kohler et
al., 2002a) are indicated (filled squares). Sites
130–140 in the putative first extracellular linker
(ECL-1) and 532–538 in the predicted fourth
extracellular linker (ECL-4) were mutated to cys-
teines in this study (gray-filled squares) (B) Com-
parison of the amino acid sequences for the pre-
dicted transmembrane domains flanking ECL-1
(TMD-1 and -2) and ECL-4 (TMD-7 and -8) show
a high degree of homology between different iso-
forms of the type II Na/Pi cotransporter family
(SLC34). Bold lettered amino acids in ECL-1
and ECL-4 for the rat isoform were mutated to
cysteines for the present study. Amino acids are
named using the single letter code.
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478 Cysteine Scanning of Extracellular Linkers in NaPi-IIa
R E S U L T S
Expression of Mutants and Identification of 
MTS-accessible Sites
Fig. 1 A shows the currently proposed secondary struc-
ture of the rat NaPi-IIa protein to indicate the location
of the residues in the predicted first and fourth extracel-
lular loops (ECL-1/-4) that were mutated individually to
cysteines (indicated in bold in Fig. 1 B). We injected Xe-
nopus laevis oocytes with cRNA coding for each mutant
and screened them for functional transport by using 32Pi
uptake (Fig. 2 A) and a basic electrophysiological assay
(ND100  1 mM Pi, holding potential [Vh] 	 50 mV)
(Fig. 2 B). For all mutants that gave functional expres-
sion, we detected a main band in the Western blots, the
position of which corresponded to the expected molec-
ular weight of the WT (80–100 kD) (Fig. 3). We as-
sumed that mutant Q537C in ECL-4 was not expressed
based on the Western blot data, as well as the lack of
both detectable 32Pi uptake (Fig. 2 A) and electrogenic
response (not depicted). Taken together, these findings
indicated that for the functional mutants, Cys mutagen-
esis did not affect the basic transport function and these
constructs were indistinguishable from the WT in terms
of the size of the expressed protein.
We assayed the functional activity of oocytes that ex-
pressed each mutant before and after exposure to 1
mM of the Cys-modifying reagent MTSEA for 10 min by
32Pi uptake (Fig. 2 A) and electrophysiology (ND100 
1 mM Pi at Vh 	 50 mV) (Fig. 2 B), to determine if
the Cys substitutions were made at sites that might di-
rectly or indirectly alter basic transport function. The
electrogenic response to Pi superfusion varied among
mutants and typically fell within the range 30 to 100
nA at 50 mV. Comparison of these datasets indicated
that the trends revealed by the two assays were similar;
Figure 2. Identification of functionally important sites
in ECL-1 and ECL-4. (A) 32Pi uptake of WT and mutants
before (filled bars) and after (unfilled bars) incubation
for 10 min in 1 mM MTSEA (n  10 oocytes per group).
(B) Remaining electrogenic activity (expressed as % of
the initial response) after 3–5 min exposure to 1 mM
MTSEA for n  3 oocytes/construct, measured at Vh 	
50 mV, ND100  1 mM Pi. WT response, filled bar;
mutants, open bars. ND (not determined) refers to
mutants that gave an electrogenic response 15 nA
or no measurable response to 1 mM Pi in at least three
batches of oocytes from different donor frogs. Insets show
representative recordings from three oocytes voltage
clamped to 50 mV that expressed the WT (1), G134C
(2), and F137C (3), respectively, before () and after ()
incubation for 3 min in 1 mM MTSEA. The response of
each oocyte to a 20-s application of 1 mM Pi (open
bars) and 1 mM PFA (filled bars) was recorded. Dotted
lines indicate peak of Pi-dependent response and holding
current in ND100 to aid comparison. Asterisks indicate
mutants that showed statistically significant deviations from the WT, as reported by an unpaired t test (P  0.05), applied to the normalized
data. (C) Comparison of activity after MTSEA exposure for mutants for which reliable electrophysiological data was available (ECL-1,
empty squares; ECL-4, gray-filled squares; WT, filled square) normalized to control (MTSEA) condition. Vertical error bars indicate SEM
for normalized uptake data, horizontal error bars indicate SEM from data in B. Gray bar represents mean  SEM to indicate change of
electrogenic activity observed for WT-expressing oocytes after MTSEA exposure.
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i.e., those mutants for which MTSEA treatment led to a
reduced 32Pi activity also showed reduced Pi-dependent
currents ( ), as indicated in Fig. 2 C, in which both
datasets have been normalized to the respective activi-
ties before exposure to MTSEA. A notable exception to
this general behavior was mutant G134C, which showed
the opposite behavior in the two assays; i.e., after MTS
exposure, we observed a decreased 32Pi uptake, but an
increased . Depending on the oocyte batch, the up-
take assays often showed a large spread in response that
we attributed to variability in expression level. There-
fore we focused on the electrophysiological assays to
study the mutants on an individual cell basis. We also
confirmed that the change in electrogenic activity after
MTS incubation could be reversed by incubation in the
reducing agent DTT (10 mM, 5 min) for selected mu-
tants, whereas no change in WT activity was docu-
mented (unpublished data). This finding confirmed
that the change in activity most likely resulted from the
introduction of a reducible covalent bond between the
novel cysteine and MTS reagent. Moreover, the rapidity
of the reversal in activity indicated that the number of
active transporters in the membrane had not changed
as a result of the MTS treatment.
As shown in Fig. 2 B, mutants displayed three types of
behavior, depending on their response to 1 mM Pi be-
fore and after MTSEA exposure: (1) WT-like (see Fig. 2
B, inset 1) in which little change in activity oc-
curred, found for five mutants in ECL-1 (G130C,
V132C, D135C, K138C, and D139C) and one in
ECL-4 (S532C); (2) one mutant in ECL-1 (G134C) that
showed increased activity (Fig. 2 B, inset 2); and (3)
those in which a loss of activity occurred, like F137C
(Fig. 2 B, inset 3) and others in ECL-1 (I136C and
N140C) and ECL-4 (M533C, A534C, and A538C). In
addition to cotransport mode ( ), the leak mode was
assayed electrophysiologically by measuring the re-
sponse to the blocker PFA (1 mM) (Forster et al., 1998)
under the same experimental conditions. At Vh 	 50
mV, all the functional mutants showed a reduced hold-
ing current during PFA application (IPFA), which indi-
cated that the leak mode was still viable. Two mutants
in ECL-4 (G535C and W536C) gave 32Pi uptake signifi-
cantly greater than H2O-injected cells (Fig. 2 A); how-
ever, the magnitude of the Pi-dependent currents was
typically 15 nA using oocytes from three donor frogs.
This low electrogenic activity and the absence of any
detectable effect of MTSEA on 32Pi uptake led to the ex-
clusion of these mutants from further investigation.
The invariance of  before and after MTSEA expo-
sure (G130C, V132C, D135C, K138C, and D139C in
ECL1; S532C in ECL-4), could indicate that (a) the mu-
tated sites were functionally unimportant, (b) other
characteristics were modified that were not identified
under the assay conditions, or (c) the sites were not ac-
IPi
IPi
IPi
IPi
cessible from the external medium by MTSEA. To test
the latter possibility, we incubated mutant-expressing
oocytes in MTSEA-Biotin and performed a streptavidin
precipitation with immunodetection using an antibody
raised against the NH2 terminus of the NaPi-IIa pro-
tein. We used the mutant S460C in ECL-3 (Fig. 1 A),
which we have previously shown to be accessible by
MTSEA (Lambert et al., 1999a), and WT-expressing oo-
cytes as positive and negative controls, respectively. As
shown in Fig. 3, except for D135C (ECL-1) and W536C
and Q537C (ECL-4), MTSEA-biotin was able to bind to
all mutants, which confirmed the accessibility of these
linkers from the external medium.
Rate of MTS Modification Reveals Differences 
in Apparent Accessibility
We estimated the rate of the Cys modification reaction
for mutants that showed a significant change of co-
transport function after MTS exposure under stan-
dard assay conditions, by measuring  after successive
exposures to a fixed concentration of MTS reagent.
The MTS reagent concentration was chosen initially by
trial and error so that a 2-min exposure resulted in an
intermediate change of activity, typically in the range
30–60% of the initial response. The test concentration
was found to vary over two orders of magnitude, de-
IPi
Figure 3. Accessibility of cysteine mutants in ECL-1 (A) and
ECL-4 (B) by MTSEA-Biotin. Western blots show streptavidin
precipitates of MTSEA-biotinylated oocytes (top) and the corre-
sponding whole cell lysates (bottom) from oocytes that expressed
the indicated mutants probed with an antibody raised against the
NH2 terminus of NaPi-IIa. Biotinylation data have been combined
from several assays made from different batches of oocytes. In
each assay, WT and water (H2O) injected oocytes were used as
negative controls, and oocytes injected with cRNA coding for the
mutant S460C (Lambert et al., 1999a) were used as a positive
control. The band in the range 80–100 kD confirms that the
labeled protein is NaPi-IIa. White lines indicate that intervening
lanes have been spliced out.
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480 Cysteine Scanning of Extracellular Linkers in NaPi-IIa
pending on the mutation site (Table I). Fig. 4 A shows a
representative record from an oocyte that expressed
mutant F137C (ECL-1) during repeated exposure to 10
M MTSET. After each exposure and washout, the re-
sponse to Pi was tested and the holding current was al-
lowed to recover to the initial baseline before the next
exposure. After normalization, these data were fit with
a single exponential function (Eq. 1). Under the as-
sumption that the MTS reagent was always in excess, we
could estimate the effective second order reaction rate
(k*) (Table I). Impermeant (MTSET) and semi-per-
meant (MTSEA) reagents were used to confirm the sid-
edness of the reaction, i.e., to confirm that modifica-
tion occurred from the external medium in the present
study. Fig. 4 (B and C) illustrates the behavior of se-
lected mutants from ECL-1 and ECL-4, respectively.
Three features were readily apparent. First, there was
a finite response to Pi after the reaction was complete,
indicated by the nonzero plateau ( 
). 
 varied de-
pending on the site of mutation and the type of MTS
reagent used. For mutant A538C (ECL-4), the time win-
dow used for the assay (15 min) did not allow the reac-
tion to reach completion using 1 mM of reagent. Incu-
bation at longer times indicated that the plateau was
10% of the initial amplitude (unpublished data). Sec-
ond, with the exceptions of G134C, N140C (ICL-1),
and A538C (ECL-4), MTSET incubation resulted in sig-
nificantly faster reaction rates compared with MTSEA
applied at the same concentration (Table I). Third, the
reaction rates for mutants with cys substitutions in ECL-1
were faster than those in ECL-4.
We previously reported that oocytes that expressed
the flanking mutations in ECL-4 (S532C and A538C)
did not show a significant loss of transport function
when exposed to MTSEA at 100 M (Lambert et
al., 1999a). However, in the present study, at 10-fold
IPi IPi
Figure 4. Determination of MTS-Cys reaction
rates for mutants that showed a change of activity
after MTS exposure. (A) Representative recording
of current from an oocyte that expressed mutant
F137C after successive applications of MTSET
(10 M) (light gray bars). The cumulative ex-
posure time (min) is indicated above each test
response. Test substrates Pi (1 mM, black bars)
and PFA (1 mM, dark gray bars) were applied for
20 s. (B and C) Pi-dependent currents at Vh 	
50 mV, normalized to the initial value plotted as
a function of cumulative MTS reagent exposure
time for selected mutants in ECL-1 (B) and ECL-4
(C). Cells were exposed to either MTSEA (filled
squares) or MTSET (open squares) for the cu-
mulative time indicated and at the concentrations
given in Table I. Continuous line is a fitted single
exponential function with plateau (Eq. 1) from
which the reaction rate and plateau were esti-
mated. Each data point is pooled from 3 cells.
Broken lines indicate plateau levels ( 
) esti-
mated from the fit of Eq. 1 (Table I).
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481 Ehnes et al.
greater MTSEA concentration, significant loss of func-
tion was observed for A538C, but still not for S532C
(Fig. 2 B). Additional electrophysiological assays (un-
published data) on mutant S532C showed 20% loss
of response to 1 mM Pi (Vh 	 50 mV) when exposed
to 1 mM MTSEA for 10 min and 40% after 25 min
(unpublished data; n 	 3). Because of its low reactivity
compared with the other mutants in ECL-4, this site was
considered only marginally accessible. At 1 mM con-
centration, it is possible that MTSEA was also present
intracellularly, due to its reported membrane perme-
ability (e.g., Holmgren et al., 1996), and therefore the
loss of cotransport function may have been due to cyto-
solic action on other, internally accessible cysteines.
However, exposure to 1 mM of MTSET also led to a
comparable loss of activity for A538C, albeit with slower
reaction rates (Fig. 4 C; Table I). This confirmed that
the novel cysteines were accessible from the extracellu-
lar medium, in agreement with their predicted topol-
ogy and the surface biotinylation assay.
Substrate Activation Unaffected by Cys Substitution 
and Cys Modification
The finite activity that remained at the completion of
the MTS modification reactions suggested that kinetic
properties of the mutated cotransporter were sensitive
to cys modification. The most likely explanation would
be a reduction (or increase, in the case of G134C) of
the apparent substrate affinities at 50 mV. We there-
fore screened all the functional mutants to compare
their substrate activation properties before and after a
5-min application of 1 mM MTSEA. To detect large de-
viations from the WT behavior of the apparent affini-
ties for Pi ( ) and Na (KmNa), we applied a two-
point assay, because in the case of poorly expressing
mutants, a complete dose response could be difficult to
obtain due to contamination from endogenous cur-
rents at low substrate concentrations. We have previ-
ously applied these assays to identify a mutant in the
first intracellular linker region that showed significantly
Km
Pi
decreased apparent substrate affinities compared with
the WT (Kohler et al., 2002a).
Pi activation was assayed by comparing the ratio of
the responses to 0.1 mM Pi and 1 mM Pi for superfu-
sion in ND100, termed the Pi activation index. Simi-
larly, a Na activation index, given by the ratio of the
responses to 1 mM Pi for superfusion in ND50 and
ND100, was used to quantitate the Na activation. We
confirmed the sensitivity of using this assay with simula-
tions in which we assumed the Pi and Na activation
characteristics could be described by the modified Hill
equation. For Pi activation (Fig. 5 A, left), the typical
range of the index for the WT, based on assays per-
formed in this study as well others (Lambert et al.,
2000; Kohler et al., 2002a), should allow detection of
changes in  outside the range 0.05    0.12
mM. For the Na activation (Fig. 5 A, right), we would
conservatively expect to detect changes in KmNa outside
the range 40  KmNa  60 mM. For example, if in the
case of mutant G137C, the 60% decrease in the electro-
genic response to 1 mM Pi after MTSEA exposure were
due only to an increase in the apparent  from the
typical WT value of 0.06 mM to 1.65 mM, the Pi activa-
tion index would decrease from 0.66 to 0.15, based
on a simple Michaelian model for Pi activation and the
same maximum transport rate  MTSEA.
As shown in Fig. 5 B, for all functional mutants, both
activation indices lay within or close to the WT range.
Moreover, the indices before and after MTS exposure
were similar for individual mutants. This suggested that
at 50 mV, assuming an invariant Na:Pi 3:1 stoichiom-
etry and that the degree of cooperativity of Na bind-
ing does not deviate significantly from the WT, neither
the cys substitution nor MTS modification had a signifi-
cant effect on the apparent substrate affinities (
and KmNa), and was most likely not the underlying rea-
son for the altered transport activity.
Cys Substitution and Cys Modification Alter Voltage Dependency
Further insight into the mechanism underlying the
changes in transport activity after cys modification was
Km
Pi Km
Pi
Km
Pi
Km
Pi
T A B L E  I
Reactivity of Mutated Sites

 k* (M1s1)
Linker Site c (mM) MTSEA MTSET MTSEA MTSET
ECL-1 G-134 0.01 1.81  0.03 2.10  0.08 455  42 206  27
I-136 0.01 0.58  0.03 0.52  0.03 835  134 1170  250
F-137 0.01 0.24  0.02 0.07  0.05 651  67 1470  300
N-140 0.1 0.60  0.02 0.60  0.13 122  23 109  21
ECL-4 M-533 0.5 0.24  0.01 0.19  0.01 13.7  0.9 37.1  1.8
A-534 0.1 0.54  0.03 0.63  0.06 60.1  10.8 75.2  24.4
A-538 1.0 0 0 2.67  0.11 1.97  0.08
Each entry is the mean  SEM obtained from the fit of Eq. 1 to data as illustrated in Fig. 4 (B and C). For A538C, the best fit was obtained by assuming 
 	 0.
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482 Cysteine Scanning of Extracellular Linkers in NaPi-IIa
obtained from the current–voltage (I–V) relationships
for Pi-dependent current. These were determined for
superfusion with ND100 in response to the application
of 1 mM Pi over voltage window 120  V  20 mV,
in which contamination by endogenous currents was
negligible. I–V data for four mutants that showed signif-
icantly changed activity after MTSEA treatment (1 mM,
3–5 min), G134C, I136C, F137C (ECL-1), and M533C
(ECL-4), are shown in Fig. 6 A. Similar I–V data was also
obtained using the positively charged MTSET and the
negatively charged MTSES (unpublished data). To ac-
count for differences in expression levels between oo-
cytes that expressed the same mutant, I–V data were
normalized to the magnitude of  at 100 mV (1 mM
Pi) before MTSEA exposure for WT, I136C, F137C and
M533C. In the case of G134C, data were normalized to
the magnitude of  after MTSEA exposure to aid com-
parison with the WT data. For the WT, MTSEA, MTSET,
MTSES treatment at concentrations up to 10 mM re-
sulted in insignificant changes to  over the voltage
window shown (unpublished data).
IPi
IPi
IPi
The I–V curves of three mutants that showed a signif-
icant decrease in both 32Pi uptake (Fig. 2 A) and elec-
trogenic activity at 50 mV after MTS exposure (Fig. 2
B), I136C (Fig. 6 A, 1), F137C (Fig. 6 A, 2), and M533C
(Fig. 6 A, 3), each showed only a small deviation from
the normalized WT I–V relation before MTS exposure.
This indicated that the cys substitution was reasonably
well tolerated at these sites. At 0 mV after MTS incuba-
tion, there was a loss of transport activity, compared
with WT, with the relative residual activity of F137C be-
ing significantly lower than the other mutants. Interest-
ingly, the I–V data for M533C  MTS showed a negative
slope over the voltage window used for these assays,
whereas I136C  MTS and F137C  MTS showed cur-
vilinear I–V relationships. Mutant G134C (Fig. 6 A, 4),
which gave a reduced 32Pi uptake (Fig. 2 A), but in-
creased electrogenic activity at 50 mV (Fig. 2 B) also
exhibited an I–V relationship with a negative slope be-
fore MTS exposure like M533C  MTS. After MTS ex-
posure, the normalized I–V data for G134C showed a
curvilinear I–V relationship compared with the WT.
Figure 5. Screening for deviations from WT behav-
ior of substrate activation kinetics at 50 mV using a
two-point assay. (A) Two-point assay sensitivity for Pi
activation (left) and Na activation (right). Continu-
ous lines are the Pi activation index (ratio of response
in 100 mM Na to 0.1 mM Pi and 1 mM Pi) as a
function of apparent affinity for Pi ( ) and Na
activation index (ratio of response to 1 mM Pi in
50 mM Na and 100 mM Na) as a function of ap-
parent affinity for Na (KmNa), respectively. Indices
were determined as a function of  or KmNa using
the modified Hill equation to describe the electro-
genic response to Pi,  	 max ( )/(   ),
where S is the concentration of the variable substrate,
KmS is the apparent affinity constant, nH is the Hill
coefficient (nH 	 1.0 for Pi activation, nH 	 2.5 for
Na-activation; Forster et al., 1998, 1999), and max
is the Pi-dependent change in holding current at the
saturating limit. In general, KmS and max can also
depend on the concentration of the invariant
substrate and holding potential (Vh). Lower test
concentration was chosen close to previously re-
ported estimates for the WT apparent affinity, and
upper test concentration was chosen close to the
saturation concentration for Pi or maximum usable
Na concentration, for the Pi and Na activation
screens, respectively. For each case, the gray bar
represents range of index values observed for WT-
expressing oocytes (n 	 9, three donor frogs).
Vertical lines indicate typical  for WT (0.06 mM)
and KmNa for WT (50 mM) at 50 mV, previously
reported (e.g., Forster et al., 1998), respectively. (B)
Pi activation index (top) and Na activation index
(bottom), where each point is mean  SEM for 4
oocytes. Gray bars indicate typical range observed for
WT-expressing oocytes measured under the same ex-
perimental conditions. ND, not determined; MTS,
filled squares; MTS, empty squares.
Km
Pi
Km
Pi
IPi IPi S
nH SnH KmSnH
IPi
IPi
Km
Pi
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483 Ehnes et al.
The negative slopes for G134C  MTS and M533C 
MTS were inconsistent with the expected behavior of
an electrogenic secondary-active transport system in
which one net positive charge is transported per cycle
(Forster et al., 1998). However, we could reconcile this
apparent anomaly when we took account of an error in-
troduced by the subtraction procedure used to obtain
. In these assays, we eliminated oocyte endogenous
currents by subtracting the holding current in ND100
from the current in ND100  Pi. However, if the leak
and cotransport modes are assumed to be mutually ex-
clusive (Kohler et al., 2002b), this procedure would un-
derestimate the true cotransport mode current by an
IPi
amount equal to the leak, if we assume that it is fully
suppressed in the presence of 1 mM Pi. The leak mode
activity was estimated by recording the change in hold-
ing current when superfusing in 1 mM PFA (IPFA).
Fig. 6 B shows the Pi-dependent and leak currents for a
representative oocyte that expressed M533C (B) and
G134C (C) before and after incubation in 1 mM
MTSEA for 3 min. The effect of MTS exposure on the
leak current was minimal over the voltage range 120 
V  0. For V  0 mV, we found that endogenous Cl
currents could also be induced by PFA in noninjected
oocytes, and these data were therefore considered un-
reliable. When  was corrected for the leak error byIPi
Figure 6. Current–voltage (I–V) curves for selected mutants. (A) Mutants that showed significantly decreased electrogenic activity at
50 mV after MTSEA exposure: I136C (1), F137C (2) in ECL-1, and M533C (3) in ECL-4, before MTSEA exposure (filled squares) and
after 3–5 min exposure to 1 mM MTSEA (empty squares) (n  4). G134C (4) in ECL-1 showed increased electrogenic activity at 50 mV
after MTSEA exposure. Each data point is the change in holding current induced by 1 mM Pi (pH 7.4, in ND100), normalized to the
magnitude of  at 100 mV, 1 mM Pi, before MTSEA exposure. For G134C, the data were normalized to the magnitude of  at 100 mV
after MTSEA exposure. WT steady-state I–V data for  (filled circles) for WT-expressing oocytes, normalized to the magnitude of  at
100 mV (n 	 4), are superimposed. SEMs smaller than symbol size are not shown. (B) I–V data showing the respective leak current (top)
and Pi-dependent current (1 mM Pi) (bottom) for a representative oocyte that expressed M533C before (filled squares) and after (empty
squares) MTSEA exposure; data points joined by dotted lines. The leak was estimated from the response to super fusion in 1 mM PFA
(IPFA). The Pi-dependent currents were leak corrected by adding the respective leak values at each test potential before MTSEA exposure
(filled diamonds) and after MTSEA exposure (empty diamonds); data points joined by continuous lines. (C) I–V data showing the respective
leak current (top) and Pi-dependent current (1 mM Pi) (bottom) for a representative oocyte that expressed G134C before (filled squares)
and after MTSEA exposure (empty squares); data points joined by dotted lines. The Pi-dependent currents were leak corrected by adding
the respective leak values at each test potential before MTSEA exposure (filled diamonds) and after MTSEA exposure (empty diamonds);
data points joined by continuous lines.
IPi IPi
IPi IPi
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484 Cysteine Scanning of Extracellular Linkers in NaPi-IIa
adding IPFA at each potential, the leak-corrected 
data now showed a positive slope with voltage-indepen-
dent rate-limiting behavior at hyperpolarizing poten-
tials for M533C  MTS and G134C  MTS.
The unique behavior of the G134C steady-state I–V
data before and after MTS exposure can also account
for the apparent anomaly between the 32Pi uptake assay
and the electrophysiological assay at Vh 	 50 mV for
this mutant. As shown in Fig. 6 C there is a crossover of
the leak-corrected G134C I–V data before and after
MTS exposure at approximately 40 mV for this oo-
cyte. Under voltage clamp conditions for Vh  50 mV,
we would therefore predict an increased cotransport
activity after MTS exposure. However, for the 32Pi assay
conditions used in this study, the membrane potential
(Vm) was undefined. Therefore, externally applied Pi
would induce a net inward positive charge movement
(3 Na  1 HPO42 per cycle) that would depolarize
the oocyte membrane. If the shift in Vm were more pos-
itive than the crossover potential, a reduced uptake
would be expected, since 32Pi uptake and net translo-
cated charge are tightly coupled for electrogenic type
II Na/Pi cotransporters (Forster et al., 1999).
To test this hypothesis, we measured the change in
membrane potential (Vm) with the voltage clamp loop
open before and after MTS exposure. For the represen-
tative G134C-expressing oocyte in Fig. 6 C, application
of 1 mM Pi induced a change in Vm from 28 mV to 5
mV, whereas after MTS exposure, Vm changed from
35 to 10 mV. For a given cell impedance, the Pi-
dependent change in Vm is proportional to the net
charge translocated, which is a function of the number
of transporters in the membrane (assumed constant)
and the transporter turnover rate. It follows from these
data that we would expect a reduced 32Pi uptake after
MTS exposure, as we observed. We found that this re-
sult was also consistent with the corresponding currents
at the Vm reached during Pi application (MTS, 56
nA; MTS, 42 nA), which we found by interpolation
of the leak-corrected I–V data of Fig. 6 C. The reduced
depolarizing shift in Vm after MTS exposure was con-
firmed for a batch (n 	 9) of G134C-expressing oo-
cytes, under the same conditions as for the tracer flux
assay. The change in Vm due to Pi superfusion was
31  1 mV for MTS, and this decreased to 19  1
mV for MTS. These findings serve to underscore the
importance of defining the membrane potential in trans-
port assays involving electrogenic membrane proteins.
From the I–V data of Fig. 6 A, it was obvious that the
effect of cys substitution at Gly-134 and modification of
Cys-136, Cys-137C, and Cys-533 was to reduce the trans-
port activity induced by 1 mM Pi over a wide voltage
range. By normalizing the leak-corrected I–V data to
V 	 0, the relative effect of hyperpolarizing membrane
potentials on the cotransport activity before and after
IPi
MTS exposure was determined (Fig. 7 A). These data
showed that cys substitution at Ile-136 and Met-533 re-
sulted in constructs with a voltage dependency that was
indistinguishable from the WT. Cys modification at
these sites increased (I136C  MTS) and decreased
(M533  MTS), respectively, the response to changes
in membrane potential in the hyperpolarizing direc-
tion relative to the WT. Cys substitution at Phe-137 gave
an increased voltage dependency compared with the
WT that was further augmented after MTS exposure,
like I136C  MTS. Finally, cys substitution at Gly-134
gave a reduced voltage dependency compared with the
WT that was comparable to M533C  MTS. After MTS
exposure, the voltage dependency of G134C was similar
to that of I136C  MTS.
Figure 7. Cysteine engineering at sites in ECL-1 and ECL-4
induces deviations from WT voltage dependency. (A) Voltage
dependency of G134C (squares), I136C (triangles), F137C (in-
verted triangles), and M533C (diamonds), before (filled symbols)
and after (open symbols) incubation in MTSEA (1 mM, 3 min).
Pi-dependent currents, corrected for leak, were normalized to the
response at 0 mV. The ordinate scale represents the relative
change in  as a function of membrane potential. Data pooled
from n  4 cells. WT data is represented by continuous line. (B)
Voltage dependency index for all functional mutants given by ratio
of response to 1 mM Pi at 100 mV to that at 0 mV (100 mM Na)
before (filled squares) and after (open squares) MTS treatment
(1 mM MTSEA, 3 min). Continuous reference line indicates WT
index. Dotted reference line indicates that G134C-MTS, S532C 
MTS, and M533C  MTS have the same index. Arrows indicate
direction of voltage dependency change for selected mutants after
MTS incubation.
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485 Ehnes et al.
To quantify changes in voltage dependency after
MTS exposure of other functional mutants that had
shown little or no change in electrogenic activity at
50 mV (Fig. 2 B), we assigned a voltage dependency
index to each mutant. This was given by the ratio of
leak-corrected  at 100 mV to  at 0 mV, before and
after MTS exposure (Fig. 7 B). This index represents
the change in cotransport activity for a voltage change
from 0 to 100 mV. Cys substitution produced changes
in this index relative to the WT for nearly all mutants.
Mutants that showed no change in activity after MTS
exposure also showed no significant change in their re-
spective voltage dependency indices (G130C, V132C,
D135C, K138C, D139C in ECL-1 and A534C, S532C in
ECL-4); however, the cys substitution itself resulted in al-
tered voltage dependencies compared with the WT. The
general trend was for the voltage dependency index to
increase after cys modification in both ECL-1 and ECL-4,
with the notable exception of M533C in ECL-4.
D I S C U S S I O N
In this study of the structure–function relationships of
sites in putative external linkers ECL-1 and ECL-4 of
the rat NaPi-IIa isoform, SCAM yielded both structural
and functional information. First, it established the lo-
cation of substituted sites in hydrophilic regions acces-
sible from the external medium, in agreement with
current topological predictions. Second, based on an
analysis of the steady-state I–V relationships before and
after cys modification, we show that cysteine engineer-
ing at sites in each linker determines the sensitivity of
cotransport activity to changes in membrane potential.
To interpret our data, which is based on the introduc-
tion of novel Cys residues in the WT backbone, we
made a tacit assumption that the target Cys residue was
the novel Cys itself and not one or more of the 12 na-
tive Cys residues. Ideally, SCAM should be performed
on a cys-less backbone to avoid ambiguities that could
arise if the introduction of a novel Cys exposes a previ-
ously inaccessible and functionally important native
Cys (Kaback et al., 2001; Kamdar et al., 2001). Unfortu-
nately, a cys-reduced construct of NaPi-IIa shows signifi-
cantly lower transport activity compared with the WT
(Kohler et al., 2003) and this would exacerbate de-
tailed kinetic analyses. Nevertheless, three pieces of evi-
dence support the validity of the above assumption: (1)
when removed singly, no native Cys appears to be criti-
cal for viable cotransport function (Lambert et al.,
2000); (2) up to eight Cys can be removed, while re-
taining transport function (Kohler et al., 2003), the re-
maining four being involved in two disulfide bridges
(Lambert et al., 2000; Kohler et al., 2003); and (3) in-
troduction of a Cys at site 460, previously found to be
functionally important for the WT backbone (Lambert
IPi IPi
et al., 1999b), shows the same behavior in the cys-
reduced NaPi-IIa (Kohler et al., 2003).
Accessibility and Membrane Topology
Although we used MTSEA as the standard probe re-
agent, exposure to impermeant MTSET gave qualita-
tively similar results. This confirmed that the sites were
accessible from the external medium only. Small differ-
ences in reactivity between MTSEA and MTSET were
observed in the rates of modification (i.e., the rate of
change of the electrogenic activity) at different sites in
ECL-1 and ECL- 4 (Table I). The faster reaction rates of
MTSET for most mutants most likely reflect the higher
reactivity of this reagent with small thiols compared with
MTSEA (Karlin and Akabas, 1998). For G134C and
A538C, MTSEA was more reactive than MTSET, per-
haps because the greater bulk of MTSET restricts its ac-
cess to these sites. As summarized in Fig. 8, the effective
second order reaction rate constants lay within the
range of values that we have previously reported for Cys
mutants in ECL-3 (Lambert et al., 2001) and establish
conclusively that these three regions are accessible from
the external aqueous environment. Rates of modifica-
tion for extracellularly accessible sites in other transport
proteins such as the excitatory amino acid transporter
(EAAT1) (e.g., Leighton et al., 2002), the mitochon-
drial citrate transporter (Ma et al., 2004), and the sero-
tonin transporter (SERT) (Chen et al., 1997) have been
reported to lie in the same range as we found for NaPi-
IIa. In the present study, the modification rates for mu-
tants in ECL-1 were consistently faster than those in
ECL-4. This would suggest that ECL-4 was less accessible
from the extracellular medium. At one site in ECL-1
(Asp-135) and one site in ECL-4 (Trp-536) we were un-
Figure 8. Graphical representation of accessibility of three
putative extracellular linkers based on effective second order
reaction rate k* plotted on a logarithmic scale (filled squares). A
larger k* indicates that the site has a greater accessibility from the
external aqueous medium. Sites that were labeled with MTSEA-
Biotin, for which the respective mutants showed no detectable
change in activity, are indicated (empty squares). Data for ECL-1
and ECL-4 were obtained from this study (Table I); data for ECL-3
were replotted from a previous study (Lambert et al., 2001).
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486 Cysteine Scanning of Extracellular Linkers in NaPi-IIa
able to detect the novel cysteines using the biotinylation
assay, which indicated that these cysteines were inacces-
sible, either because of the bulk of MTSEA-Biotin or the
specific folding of the linkers at these sites.
The functional consequences of exposure to MTS re-
agents varied considerably among neighbors. For ex-
ample, Cys-135 could not be labeled with MTSEA-Bio-
tin, and, consistent with this result, mutant D135C
showed no change in its kinetics after MTS exposure.
In contrast, we could detect its immediate neighbors
(Cys-134 and Cys-136) with MTSEA-Biotin; however,
G134C and I136C showed significantly altered voltage
dependencies after MTS exposure. In other cases, cys
substitution did not result in MTS-sensitive mutants, al-
though we could successfully detect the novel cysteines
with the biotinylation assay (e.g., Cys-130, Cys-132, Cys-
138, and Cys-139). This suggested that these sites were
not functionally critical. Finally, the striking behavior of
mutant G134C indicated that the native Gly at this site
is crucial for normal electrogenic behavior. Gly-134 is
conserved among a number of NaPi-II isoforms, and its
small size might confer a unique flexibility to this linker
and the associated transmembrane domains that is re-
stricted when replaced with a bulkier Cys.
Modulation of Steady-state Voltage-dependent Kinetics
In a previous SCAM study, a cluster of mutants was
found in ECL-3, most of which showed full suppression
of cotransport mode activity after MTS exposure (Lam-
bert et al., 2001). These constructs yielded characteris-
tically similar Pi and PFA responses at the end of the
modification reaction, from which we concluded that
Pi could interact with NaPi-IIa and thereby inhibit the
leak mode, but the cotransport mode was suppressed.
This led us to postulate that these sites are associated
with the transport pathway itself (Lambert et al., 1999a,
2001; Kohler et al., 2002a,b). In the present study, all
the MTS-sensitive mutants, except A538C, showed a Pi-
dependent electrogenic response at 50 mV that as-
ymptoted to a nonzero level, at the end of the modifica-
tion reaction. This behavior suggested that they may
not be directly associated with the transport pathway or
the substrate recognition site as, in the latter case, ki-
netic analysis of these mutants under voltage clamp
conditions revealed that apparent substrate affinities
appeared unchanged, either from cys substitution or
cys modification. On the other hand, cysteine engi-
neering at sites in ECL-1 and ECL-4 resulted in signifi-
cantly altered voltage-dependent activity compared with
the WT, depending on the site of cys substitution or cys
modification.
Mutants could be broadly classified according to
whether there was increased, decreased, or unchanged
activity compared with the WT for hyperpolarizing
membrane potentials (0 to 100 mV) (Fig. 7 B). The
finding that most mutants deviated from WT behavior
suggested that the amino acid residues in ECL-1 and
ECL-4 were critical determinants of the NaPi-IIa volt-
age-dependent kinetics. Several “hot spots” emerged
from these assays, for which the voltage-dependent ac-
tivity of the corresponding mutants deviated signifi-
cantly from the WT, either due to cys substitution
alone, cys modification, or both. For example, cys sub-
stitution at Ile-136 increased the voltage-dependent ac-
tivity, whereas at the neighboring Phe-137, cys substitu-
tion was well tolerated. However, cys modification at
both sites led to a significantly increased voltage-depen-
dent activity. Interestingly, cys substitution at Gly-130
and Ile-136 led to the same increase in activity. This was
mimicked by cys modification of Cys-134, intermediate
in the amino acid sequence in ECL-1, and by cys substi-
tution at Ala-534 and Ala-538 in ECL-4. Such similar be-
havior indicated that engineering at sites in each linker
had induced the same voltage-sensitive conformational
changes in the protein. Complementary behavior was
also documented, in which the opposite effects on volt-
age dependency were found for cys substitution at Gly-
134 in ECL-1 and Met-533 in ECL-4. G134C-MTS and
M533C  MTS both exhibited a weakly voltage-depen-
dent activity, whereas that of G134C  MTS exceeded
the WT, and the voltage dependency of M533C  MTS
was indistinguishable from the WT. Interestingly, cys
substitution at the Ser-532 resulted in the same weak
voltage-dependent activity as shown by M533C  MTS
with little change in activity after MTS exposure. This
suggested that the conformational change induced by
modification of Cys-533 in ECL-4 was the same as that
made by introducing a cysteine at the preceding site
(Ser-532), or at Gly-134 in ECL-1. The novel comple-
mentary behavior of G134C and M533C is the subject
of a more detailed kinetic analysis in the accompanying
study (Ehnes et al., 2004).
In addition to relative changes in voltage-dependent
activity, the I–V behavior revealed that for G134C 
MTS and M533C  MTS, the maximum transport rate
at the hyperpolarizing limit was also affected. In each
case, the leak-corrected I–V curves showed rate-limiting
behavior in the same voltage range where the WT,
G134C  MTS, and M533C  MTS voltage-dependent
activity was still approximately linear. The overall be-
havior of these mutants suggested that the cys substitu-
tion and cys modification at these sites had (a) slowed
one or more voltage-independent rate constants in the
transport cycle and (b) induced a depolarizing shift in
voltage-dependent transitions associated with either the
empty carrier, first Na binding transition, or both, in
accordance with the current alternating access model
for NaPi-IIa (Forster et al., 2002).
Are sites in ECL-1 and ECL-4 part of the voltage-sens-
ing mechanism of NaPi-IIa? Three pieces of evidence
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suggest this is not the case. First, one might expect mo-
bile charged or polar residues to constitute the voltage
sensor and their removal would have a dramatic effect
on the electrogenic behavior of the protein. Although
ECL-4 has no charged residues, three sites in ECL-1
(D-135, K-138, and D-139) could be potential candi-
dates, but when replaced by cysteines, the resulting mu-
tants were still electrogenic (Fig. 7 B), albeit with only
small deviations in voltage dependency from the WT.
Similarly, substitution of the polar Ser-532 (ECL-4) with
a nonpolar Cys weakened the voltage dependency (Fig.
7 B). These findings suggest that the particular charged
or polar residues may certainly interact with the puta-
tive voltage-dependent elements to modulate the volt-
age dependency of transport, but the intrinsic voltage
sensitivity of the protein remains intact. In another
electrogenic cotransporter, the Na-coupled glucose
transporter (SGLT-1), polar residues have been shown
to modulate charge movements and alter empty carrier
kinetics without affecting the overall apparent valency
of the cotransporter (Panayotova-Heiermann et al.,
1994). Second, one member of the SLC34 family, the
renal type IIc isoform, is electroneutral (Segawa et al.,
2002; unpublished data). NaPi-IIc has a high homology
with the electrogenic type IIa Na/Pi cotransporter,
with both charged residues in ECL-1 being conserved
(Fig. 1 B). Third, the same MTS-induced changes to
the voltage dependency occurred using either posi-
tively or negatively charged MTS reagents. This sug-
gests that the charge introduced by these reagents ei-
ther lies outside the transmembrane field or does not
interact with the intrinsic voltage-sensing elements.
In summary, the outermost external linkers of the
NH2- and COOH-terminal halves of NaPi-IIa contain
sites that when occupied by Cys residues, are localized
in an externally accessible, hydrophilic environment,
which is consistent with hydropathy predictions. The
native residues in these linkers are not absolutely essen-
tial for Na-coupled Pi cotransport function; however,
cys substitution or covalent modification of the novel
cysteines by externally applied MTS reagents affected
the voltage-dependent kinetics of the mutant transport-
ers. As changes in membrane potential are expected to
induce major conformational changes in the native
protein during the transport cycle (e.g., Loo et al.,
1998), the findings reported here suggest that linkers
ECL-1 and ECL-4 contain specific sites that may inter-
act directly or indirectly with mobile, voltage-sensitive
elements of the NaPi-IIa protein.
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